Anti-Diabetic Drugs Market Posts Strong Growth in India
The anti-diabetic drugs market in India grew about 21% in September per one dataset and 16.1% per another. What drove it, including GLP-1 generics.
Get the latest industry insights and trends in the pharmaceutical sector with Med Pharma News. Stay informed about groundbreaking research, regulatory updates, and market analysis.
The anti-diabetic drugs market in India grew about 21% in September per one dataset and 16.1% per another. What drove it, including GLP-1 generics.
Biopharma SHAKTI gets a 25-site clinical trial pilot as NIPER Raebareli and AstraZeneca India sign an MoU. What the pilot tests and what is undisclosed.
Soufflé Therapeutics $135 million funding backs RNA drugs for FSHD and heart failure. The treatments are experimental; no new human data were reported.
Russia lab worker death: a young employee of a plague institute died of pneumonia. WHO sees no spread, 5,500 tests found no pathogen, cause unknown.
The New York measles outbreak has 108 cases as Governor Hochul seeks HHS and CDC help after Kennedy offered support. What is confirmed so far.
The vaccine injury initiative from HHS Secretary Kennedy adds an NIH clinic, VAERS changes and a CMS proposal. See what is known and what is not.
The City Therapeutics IPO targets a valuation of up to about $956 million at $17 to $19 a share. Terms, RNAi pipeline, financials and risks.
Korea medical tourism drew about 2.01 million foreign patients in 2025, with blood tests and ultrasounds booming. See the data and the caveats.
Karnataka MLAs medical bills: RTI data shows 69 MLAs claimed ₹7.47 crore from 2023 to 2026. Top claims, the rules and what is unknown.